Danshensu for Myocardial Ischemic Injury: Preclinical Evidence and Novel Methodology of Quality Assessment Tool

• Ngā kaituhi matua: Xiao-yi Bao (Author), Qun Zheng (Author), Qiang Tong (Author), Peng-chong Zhu (Author), Zhuang Zhuang (Author), Guo-qing Zheng (Author), Yan Wang (Author)
• Hōputu: Pukapuka
• I whakaputaina: Frontiers Media S.A., 2018-12-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

Background: Danshensu (DSS) possesses unique bioactivity on the cardiovascular system. However, there is a lack of systematical summary of DSS for acute myocardial ischemia injury and no quality assessment tool for the systematical review of cell experiments. Here, we aimed to assess the preclinical...